Regulatory
PFDD: A Game Changer?
The 21st Century Cures Act (Cures Act), which was passed by Congress, includes mandates ...
Pitfalls of Generic Drug Marketing
While many advertising agencies, companies, healthcare professionals, and consumers alike may not realize it, ...
That “Can Do” Attitude
Companies that are committed to patient-centered healthcare must incorporate the patient’s voice in all ...
Exhibit Displays: Beware the FDA
Companies attending large medical meetings to showcase innovative and marketed drug products alike should ...
The Trouble with Sampling in the State of Ohio
Have you ever heard about Ohio’s Terminal Distributor of Dangerous Drugs (TDDD) licenses? Before ...
Can Cross-Functional Leaders Competently Embrace Digital Innovation?
Is your company focused on accelerating digital transformation to become more patient-centric? That’s a ...
The FDA, Clinical Decision Support Tools, and the Medical Device Industry
As patients, caregivers, and healthcare professionals rely more on digital healthcare tools and the ...
Technology, Uncertainty, and the Life Sciences at a Tipping Point
Perhaps more than any concept in the life sciences industry, change is the single-most ...
Driving Medical Communications Toward a New Future
I recently attended the Medical Affairs Professional Society’s (MAPS) inaugural annual meeting to learn ...
Is Pharma Leading the Pack with Compliant Endorser Disclosures?
In April of this year, the U.S. Federal Trade Commission (FTC) issued more than ...
Pilot Program Tests Easing FDA Regulatory Burdens for Lower Risk Medical Devices
Worries about the ability to bring new products to market are hardly new to ...
Disclosing Connections With Advertisers on Social Networking Sites
In April of this year, the U.S. Federal Trade Commission (FTC) issued more than ...
Looking Back to Move Forward
Back in the 1980s, when Direct to Consumer advertising (DTC) was initially conceived, I ...